The Expression of SIRT6 Is Associated With Treatment Outcome in Elder Patients With Oral Cancer
| Autor: | HARUKA YOSHII, KAZUMASA SEKIHARA, YUKA IDETA, SHINTARO NAKAJIMA, IKUMA KATO, MAKIKO OKUBO-SATO, KEI SUGIURA, KENJI MITSUDO, MITOMU KIOI |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Anticancer Research. 42:3815-3823 |
| ISSN: | 1791-7530 0250-7005 |
| DOI: | 10.21873/anticanres.15872 |
| Popis: | SIRT6 is one of seven human sirtuin genes and is known to act as an onco-suppressor gene in colorectal and ovarian cancers, although it is up-regulated in other cancers. Thus, SIRT6 is considered performing both tumor-suppressing and promoting roles. However, the association of SIRT6 with oral squamous cell carcinoma (OSCC) and its role in OSCC pathogenesis is currently unclear. This study aimed to investigate the expression of SIRT6 in patients with OSCC and its potential as a biomarker for early detection and prognosis prediction.Immunohistochemistry, quantitative real-time RT-PCR, and microarray analyses were performed to determine SIRT6 expression and its association with clinicopathological features in OSCC using clinical specimens.SIRT6 mRNA and protein expression levels were higher in OSCC tissues than in noncancerous tissues (p0.05). SIRT6 expression was predominant in patients aged ≥65 years and significantly correlated with shorter overall survival. In the microarray analysis, some SIRT6-associated genes, such as ANXA2, were up-regulated in OSCC.SIRT6 plays a role in tumor homeostasis, leading to a poor prognosis in OSCC. SIRT6 may represent a novel target not only for treatment, but also as a prognostic marker in OSCC. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|